DNAFORM offers innovative technology platforms for genome and transcriptome analysis. These include Cap-trapped full-length cDNA cloning, high-throughput expression profiling and promoter identification by next generation sequencing including genome annotation (Cap Analysis Gene Expression or CAGE), and point of care genotyping by SmartAmp. All our technologies gained rapid global recognition from outstanding publication records in leading scientific journals like Nature, Science, Nature Methods, and Nature Genetics. Moreover, DNAFORM is a leading clone distributor in particular offering resources from the RIKEN FANTOM Projects.
| Website | http://www.dnaform.jp/index_e.html |
| Revenue | $202.9 million |
| Employees | 7 (1 on RocketReach) |
| Technologies |
JavaScript
,
HTML
,
PHP
+11 more
(view full list)
|
| Industry | Retail, Biotechnology |
| Keywords | Genome Analysis, Next Generation Sequencing, Gene Expression Profiling, High Throughput Sequencing, Ngs, Rna Sequencing, Gene Expression, Dna Sequencing, High Throughput Screening, Genomics, Transcriptomics, Bioinformatics, Molecular Biology, Genetic Analysis |
| Competitors | Thermo Fisher Scientific, Agilent Technologies, Illumina, Biogen, Eurofins, QIAGEN, BGI Genomics, Sangamo Therapeutics, Inc., Zymergen, Inc., Genomatix AG +35 more (view full list) |
| SIC | SIC Code 513 Companies, SIC Code 51 Companies |
| NAICS | NAICS Code 423 Companies, NAICS Code 42 Companies |
Looking for a particular DNAFORM Inc. employee's phone or email?
The DNAFORM Inc. annual revenue was $202.9 million in 2026.
1 people are employed at DNAFORM Inc..
The NAICS codes for DNAFORM Inc. are [423, 42].
The SIC codes for DNAFORM Inc. are [513, 51].